Analyst Price Target is C$0.00
This price target is based on 0 analysts offering 12 month price targets for Zendesk in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.
Current Consensus is
N/A
The current consensus among 0 polled investment analysts is to n/a stock in Zendesk. This N/A consensus rating has held steady for over two years.
Zendesk
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.
Read More